1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Lupus Nephritis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Lupus Nephritis Clinical Trials by Region
2.2.2 Average Enrollment of Lupus Nephritis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Lupus Nephritis Treatment, 2019

3. Region wise Lupus Nephritis Clinical Trials
3.1 Asia Pacific Lupus Nephritis Clinical Trials by Country
3.2 Europe Lupus Nephritis Clinical Trials by Country
3.3 North America Lupus Nephritis Clinical Trials by Country
3.4 Middle East and Africa Lupus Nephritis Clinical Trials by Country
3.5 South and Central America Lupus Nephritis Clinical Trials by Country

4. Lupus Nephritis Clinical Trial Trends
4.1 Start Year wise Lupus Nephritis Clinical Trials
4.2 Phase wise Lupus Nephritis Clinical Trials
4.3 Trial Status wise Lupus Nephritis Clinical Trials
4.4 Trial Type wise Lupus Nephritis Clinical Trials

5. Lupus Nephritis Average Enrollment Trends
5.1 Average Enrollment in Lupus Nephritis Trials by Year
5.2 Average Enrollment in Lupus Nephritis Trials by Phase
5.3 Average Enrollment in Lupus Nephritis Trials by Status
5.4 Average Enrollment in Lupus Nephritis Trials by Type of Trial

6. Companies Participating in Lupus Nephritis Clinical Trials
6.1 Lupus Nephritis Trials by Sponsor Type
6.2 Lupus Nephritis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Lupus Nephritis Trials- Phase 1
7.2 Lupus Nephritis Trials- Phase 2
7.3 Lupus Nephritis Trials- Phase 3
7.4 Lupus Nephritis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Lupus Nephritis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Lupus Nephritis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Lupus Nephritis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Lupus Nephritis Clinical Trials and Enrolment
Figure 7: North America - Country wise Lupus Nephritis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Lupus Nephritis Clinical Trials and Enrolment
Figure 9: Lupus Nephritis Clinical Trials by Phase
Figure 10: Lupus Nephritis Clinical Trials by Trial Status
Figure 11: Lupus Nephritis Clinical Trials by Type
Figure 12: Lupus Nephritis Clinical Trials by Sponsor Type
Figure 13: Lupus Nephritis Clinical Trials by Leading Sponsors
Figure 14: Lupus Nephritis Average Enrollment by Phase
Figure 15: Lupus Nephritis Average Enrollment by Trial Status
Figure 16: Lupus Nephritis Average Enrollment by Type
Figure 17: Lupus Nephritis- Average Enrolment by Type of Sponsors
Figure 18: Lupus Nephritis- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Lupus Nephritis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Lupus Nephritis Clinical Trials and Enrolment
Table 5: Europe - Country wise Lupus Nephritis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Lupus Nephritis Clinical Trials and Enrolment
Table 7: North America - Country wise Lupus Nephritis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Lupus Nephritis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Lupus Nephritis Average Enrollment by Phase
Table 15: Lupus Nephritis Average Enrollment by Trial Status
Table 16: Lupus Nephritis Average Enrollment by Type
Table 17: Lupus Nephritis- Average Enrolment by Type of Sponsors
Table 18: Lupus Nephritis- Enrolment by Leading Sponsors

Companies mentioned
Astellas Pharma Inc, Aurinia Pharmaceuticals Inc, Biogen Inc, Bristol-Myers Squibb Co, C. H. Boehringer Sohn AG & Co KG, F. Hoffmann-La Roche Ltd, Immune Tolerance Network, Johnson & Johnson, Novartis AG, Parexel International Corp